Événements
Paris NASH Meeting
September 9-10, 2021
Paris
L’équipe d’ENYO Pharma sera présente à la 7è édition de cet évènement organisé par Arun Sanyal et Lawrence Serfaty.
https://www.paris-nash.org/
EASL – International Liver Congress 2021
23–26 Juin 2021
Edition Digitale
ENYO Pharma sera présente du 23 au 26 Juin 2021 au Congrès International sur le foie (EASL) et présentera un premier poster : “A phase 2 study testing FXR agonist Vonafexor in treatment naive patients with chronic hepatitis B (CHB): preliminary week 16 results” (EASL-ICL 2021 Abstract No. 2844) dans la session “Hepatitis B/D Therapy Session”:
Et un second poster “Farnesoid X receptor alpha ligands inhibit in vitro HDV replication and virion secretion and infectivity”
HBV-TAG Conférence 2021 (Sponsorship)
11-12 Juin 2021
Conférence virtuelle
ENYO Pharma a sponsorisé la conférence inaugurale virtuelle sur l’hépatite B – agents thérapeutiques de 2021.
www.hbv-tag.org
“The primary objective of the Virtual HBV-TAG Conference is to meet the educational needs of research and development stakeholders and healthcare professionals who seek to improve the lives of patients with HBV. The aim of the HBV-TAG conference is to bring together key opinion leaders from the teams of clinicians that care for patients with HBV (hepatologists and gastroenterologists) and pharmaceutical industry representatives to discuss optimized trial design,
Chronic Hepatitis B Drug Development Summit
5-6 Mai 2021
Pietro Scalfaro, notre directeur médical, présentera des résultats d’essais cliniques de notre composé principal Vonafexor au congrès “Chronic Hepatitis B Drug Development Summit” : “Targeting the Farnesoid X Receptor for the Treatment of Chronic Hepatitis B”.
“This Summit is the first-ever dedicated digital industry forum dedicated exclusively to the frontier of drug development in Chronic HBV. The two-day program explores the full spectrum of antiviral & immunomodulatory agents being investigated to achieve a functional cure in chronic HBV infection &
Immunotherapies & Innovations for Infectious Diseases Congress 2020
9-10 Décembre 2020
Edition Digitale
ENYO joindra la 4ème edition du congrès I4ID.
“The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.”
Dernière press release 